![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Motif Bio Plc | LSE:MTFB | London | Ordinary Share | GB00BVVT4H71 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.55 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
18/12/2020 20:17 | SD70- just a word of advice. Be careful what you do. Group intervention is better! | ![]() smcl | |
18/12/2020 18:04 | The more questions individually asked shows a complete lack of care for investors and I think that is a powerful trend to prove how they have treated ALL shareholders not just a few of us who have asked meaningful questions | ![]() scottdavid70 | |
18/12/2020 17:29 | Hi SD70- why don’t you put together a concise focused submission- short and to the point and get a number of shareholders here and on LSE to sign up and we could sent to the Company and it’s advisors. No point trying to do this on your own. No man is an island and all that. As a group we would be stronger. Have a think? Regards sm | ![]() smcl | |
18/12/2020 17:10 | Was it all a big con Graham Lumsden? Is the alternating title in my head | ![]() scottdavid70 | |
18/12/2020 16:55 | One more week to announce a deal and then the 28th January 2021 is just the finish line for the delist. No more of Lumsdens promises of news that isn’t either correct or never materialises 5 business days until the final chapter of “The Dark Art of Being a AIM CEO” is written | ![]() scottdavid70 | |
18/12/2020 14:00 | Another week of leaving investors totally in the dark and the PR that is spent on outside companies is just money into thin air - this case study of incompetence and opaqueness vest murkier and better for my book everyday | ![]() scottdavid70 | |
18/12/2020 10:03 | Is that good Corporate Governance given how many other financial institutions we could have used to go back to them same one that knows Motifs skeletons????? | ![]() scottdavid70 | |
18/12/2020 10:03 | Closing in on 8 months since Scavenger Hunt picked the last remaining meat of the Motif carcass. Several RTO option then on the 1st June - 30 by 12th October - it’s like the Covid RTO pandemic - next we will be told it’s a 1000... | ![]() scottdavid70 | |
18/12/2020 09:18 | Bit of communication and honesty for the people who have paid your salary isn’t much to ask is it? | ![]() scottdavid70 | |
18/12/2020 08:19 | So Motif got several offers to do a RTO due to companies wanting to get their COViD therapeutics to market. Motif then hire Peel Hunt who have failed over and over gain to realise value for investors despite making huge sums for themselves. Walbrook whom take hundred of thousands of pounds to not reply to investors. Were Peel Hunt brought in as they knew the skeletons? Why use the same company that has failed investors before with their predictions? Makes no sense? Why do Walbrook refuse to answer questions? Does anyone else smell a Graham here? | ![]() scottdavid70 | |
18/12/2020 05:17 | I heard a rumour that they called Jon Gold at his former jobs the man with the Midas touch....sadly it appears it is only for HIMSELF for investors in Motif Bio | ![]() scottdavid70 | |
18/12/2020 05:15 | Good morning wonder what Jon “deferred $325,000 salary on top of his current $325,000 for this year despite strict cost controls” Gold is working on today? The man has milked almost $1.5 million in cash from Motif but is yet to buy a share. Shareholders have been propping up is extravagant lifestyle | ![]() scottdavid70 | |
17/12/2020 14:45 | There a few of us who have contacted the relevant authorities on the legalities of no Board reviews for the members of the Board and also how they acted as one in 2019. We await what the response but every organisation I have been a part of as good Corporate Governance does individual and group reviews no matter the type of year they have had. It’s utterly bemusing they didn’t have any reviews for 2019. Actually it’s incredible | ![]() scottdavid70 | |
17/12/2020 11:30 | Lumsden too nearly $1.5 million in salary from 2018 and produced what from that outrageous sum? Not only that but he pulled the AGM forward to scurry away from Investors before the FDA revealed that not surprisingly, despite his claim that no new clinical trials were needed on the 19th Feb webcast 2019, that need a whole new Phase iii trial $1.5 million he took of shareholders investment and didn’t have the guts to face them at the AGM. Zero backbone all the at through this disgraceful saga | ![]() scottdavid70 | |
17/12/2020 11:26 | Where are the US Army trials and if nowhere why not just say so after a year and 2 months? They shout it from the rooftops and then scurry away into their Chateaux’s the moment things get a wee bit tough poor dears | ![]() scottdavid70 | |
17/12/2020 11:24 | Why when Lumsden said the Lamellare tie up wound yield results in months from May 2019 have we heard nothing still? | ![]() scottdavid70 | |
17/12/2020 11:24 | For example, how are investors not emailing Motif and Walbrook to ask about the new patents this August for Iclaprim and Sandoz every day? Your investment could depend on what that means but they won’t mention it even happened. Yet they agree there is a contract in place that investors could benefit from via a sale so therefore it stands to reason that the investors here who have been shafted by the Board to date should be informed of the potential upside these patents mean | ![]() scottdavid70 | |
17/12/2020 10:52 | I will post everyday until the 28th January about what has transpired here | ![]() scottdavid70 | |
17/12/2020 10:50 | Bi11y - that’s for me to know and the Motif Board to find out one day As for the kitchen - I most definitely wasn’t in it at 5am hunched over. I have lots to do with my life but making sure the Motif Board are not forgotten is definitely a part of it until the 28th January 2021. As I have said previously this is already close to being a finished book and a case study for investors and ultimately Directors in the future. | ![]() scottdavid70 | |
17/12/2020 09:02 | bi11y ray Valentine- you raise serious questions here. Always have sympathy for those who lose- but you have to let go!! | ![]() smcl | |
17/12/2020 08:56 | I'm picturing you in a dark kitchen hunched over a bowl of soggy cornflakes at 5 o'clock this morning, plotting the next phase of your dastardly plan to stick it to the Motif board once again. Serious question, Scott: How much of an affect did the FDA refusal actually have on your life? How bad was it on a scale of 'wife and kids left me and they took the dog too' through to 'my plans to retire to the south of France had to be put on hold a couple of years'? | bi11y ray va1entine | |
17/12/2020 05:51 | That’s YOUR money going in JON GOLDS POCKET | ![]() scottdavid70 | |
17/12/2020 05:49 | Jon Gold take home pay if a RTO happens in 2 years plus a month OVER $2 MILLION DOLLARS WOW!! Hows is that allowed???? | ![]() scottdavid70 | |
17/12/2020 05:31 | What did Non Good do in 2018 and 2019 to earn almost $1.5 million?????????? | ![]() scottdavid70 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions